Literature DB >> 24659666

WNT1 gene expression alters in heterogeneous population of prostate cancer cells; decreased expression pattern observed in CD133+/CD44+ prostate cancer stem cell spheroids.

Gamze Goksel1, Ayhan Bilir, Ruchan Uslu, Hakan Akbulut, Ummu Guven, Gulperi Oktem.   

Abstract

PURPOSE: Established cancer cell lines contain cancer stem cells (CSCs) which can propagate to form three dimensional (3D) tumor spheroids in vitro. Aberrant activation of WNT signaling is strongly implicated in the progression of cancer and controls CSCs properties. In this study we hypothesized that when cells were maintained as spheroids, the structure of CSCs could show differentiation between CSCs and non- CSCs.
METHODS: CD133+/CD44+ cancer-initiating cells were isolated from DU-145 human prostate cancer cell line monolayer cultures, propagated as tumor spheroids and compared with the remaining heterogeneous cancer cells bulk population. The expression levels of WNT1, FZD1, ADAR, APC, AXIN, BTRC, FRAT1 and PPARD genes were measured by polymerase chain reaction (PCR) array assay and the protein expression levels of WNT1, FZD and AXIN by immunohistochemistry.
RESULTS: The expression levels of WNT pathway-related molecules were found to increase in both CSCs and non- CSCs when CSCs were maintained as spheroids. However, different expression profiles were observed when CSCs and non-CSCs were compared. In spheroids, the expression levels of FZD1, APC, ADAR, WNT1, PPARD genes in CSCs decreased when compared to non-CSCs. Interestingly, when CSCs from spheroids were compared with CSCs from monolayers the most significant decrease was observed in FZD1 and increase in APC genes.
CONCLUSION: It is possible to assume that intracellular signaling of WNT-related molecules in the nucleus and/or cytoplasm might play an important role but it is independent from increased ligand expression and this expression strongly differentiate CSCs and non-CSCs population. This unexpected expression could be important for CSCs behavior and targeting this pathway could have therapeutic implications in cancer.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24659666

Source DB:  PubMed          Journal:  J BUON        ISSN: 1107-0625            Impact factor:   2.533


  5 in total

1.  FRAT1 expression regulates proliferation in colon cancer cells.

Authors:  Kongxi Zhu; Jianqiang Guo; Hongjuan Wang; Weihua Yu
Journal:  Oncol Lett       Date:  2016-10-19       Impact factor: 2.967

2.  Delivery Of Curcumin Nanoliposomes Using Surface Modified With CD133 Aptamers For Prostate Cancer.

Authors:  Qi Ma; Wei Qian; Wei Tao; Yanling Zhou; Boxin Xue
Journal:  Drug Des Devel Ther       Date:  2019-11-28       Impact factor: 4.162

3.  Frequently rearranged in advanced T‑cell lymphomas‑1 demonstrates oncogenic properties in prostate cancer.

Authors:  Wei Zhang; Hua Xiong; Yanmei Zou; Sanpeng Xu; Lanping Quan; Xianglin Yuan; Ningzhi Xu; Yihua Wang
Journal:  Mol Med Rep       Date:  2016-09-05       Impact factor: 2.952

Review 4.  Three-Dimensional Cell Cultures as an In Vitro Tool for Prostate Cancer Modeling and Drug Discovery.

Authors:  Fabrizio Fontana; Michela Raimondi; Monica Marzagalli; Michele Sommariva; Nicoletta Gagliano; Patrizia Limonta
Journal:  Int J Mol Sci       Date:  2020-09-16       Impact factor: 5.923

5.  Induced growth inhibition, cell cycle arrest and apoptosis in CD133+/CD44+ prostate cancer stem cells by flavopiridol.

Authors:  Burak Cem Soner; Huseyin Aktug; Eda Acikgoz; Fahriye Duzagac; Ummu Guven; Sule Ayla; Cag Cal; Gulperi Oktem
Journal:  Int J Mol Med       Date:  2014-09-11       Impact factor: 4.101

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.